GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Gross Margin %

WPD Pharmaceuticals (XCNQ:WBIO) Gross Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. WPD Pharmaceuticals's Gross Profit for the three months ended in Sep. 2024 was C$0.00 Mil. WPD Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was C$0.00 Mil. Therefore, WPD Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for WPD Pharmaceuticals's Gross Margin % or its related term are showing as below:


XCNQ:WBIO's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.475
* Ranked among companies with meaningful Gross Margin % only.

WPD Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for WPD Pharmaceuticals was 0.00% per year.


WPD Pharmaceuticals Gross Margin % Historical Data

The historical data trend for WPD Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Gross Margin % Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Quarterly Data
Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of WPD Pharmaceuticals's Gross Margin %

For the Biotechnology subindustry, WPD Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's Gross Margin % falls into.


;
;

WPD Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

WPD Pharmaceuticals's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

WPD Pharmaceuticals's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


WPD Pharmaceuticals  (XCNQ:WBIO) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

WPD Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


WPD Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals Business Description

Traded in Other Exchanges
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Executives
Constantine Carmichel Director

WPD Pharmaceuticals Headlines

No Headlines